Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model

BACKGROUND: A recent recalibration of the ONCOTYROL Prostate Cancer Outcome and Policy (PCOP) Model, assuming that latent prostate cancer (PCa) detectable at autopsy might be detectable by screening as well, resulted in considerable worsening of the benefit-harm balance of screening. In this study,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Public Health
Main Authors: Mühlberger, Nikolai, Boskovic, Kristijan, Krahn, Murray D., Bremner, Karen E., Oberaigner, Willi, Klocker, Helmut, Horninger, Wolfgang, Sroczynski, Gaby, Siebert, Uwe
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485506/
https://ncbi.nlm.nih.gov/pubmed/28651567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-017-4439-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki